Literature DB >> 2201320

Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients.

J Nord1, P Ma, D DiJohn, S Tzipori, C O Tacket.   

Abstract

Cryptosporidium parvum may cause severe, debilitating diarrhea in patients with AIDS. Recent anecdotal reports have suggested that hyperimmune bovine colostrum may be effective. We conducted a double-blind, controlled pilot study of hyperimmune bovine colostrum for diarrhea due to cryptosporidiosis in five AIDS patients. The patients were randomized to receive either hyperimmune or control colostrum by continuous nasogastric infusion for 10 days. All stools were collected, graded, and weighed, and the concentration of oocysts excreted was determined daily. One of the three patients treated with hyperimmune colostrum had a reduction in diarrhea and in the concentration of oocysts excreted. A second treated patient had a modest decrease in the concentration of oocysts excreted. Two patients who received control colostrum also had decreases in the volume of diarrhea but no change in the concentration of oocysts excreted. We conclude that hyperimmune colostrum with high titers of specific anti-Cryptosporidium antibody could be effective in treating patients with cryptosporidiosis. However, more studies of cow colostral immunoglobulin need to be performed so that the efficacy of this treatment can be assessed more thoroughly.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201320     DOI: 10.1097/00002030-199006000-00015

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  39 in total

Review 1.  Passive immunity against human pathogens using bovine antibodies.

Authors:  C Weiner; Q Pan; M Hurtig; T Borén; E Bostwick; L Hammarström
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Effect of bovine colostrum-based food supplement in the treatment of HIV-associated diarrhea in Northern Uganda: a randomized controlled trial.

Authors:  F O Kaducu; S A Okia; G Upenytho; L Elfstrand; C-H Florén
Journal:  Indian J Gastroenterol       Date:  2011-12-13

3.  Criterion-related validity of a diarrhea questionnaire in HIV-infected patients.

Authors:  Nathan M Thielman; Philip F Rust; Richard L Guerrant
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

Review 4.  Back to the future: antibody-based strategies for the treatment of infectious diseases.

Authors:  H Barbaros Oral; Cüneyt Ozakin; Cezmi A Akdiş
Journal:  Mol Biotechnol       Date:  2002-07       Impact factor: 2.695

Review 5.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

Review 6.  Therapeutic potentials of bovine colostrums.

Authors:  B R Thapa
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

Review 7.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

8.  Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.

Authors:  F J Enriquez; M W Riggs
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Cloning and expression of a cDNA encoding epitopes shared by 15- and 60-kilodalton proteins of Cryptosporidium parvum sporozoites.

Authors:  M C Jenkins; R Fayer; M Tilley; S J Upton
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: a prospective cohort study.

Authors:  Poonum S Korpe; Yue Liu; Abdullah Siddique; Mamun Kabir; Katherine Ralston; Jennie Z Ma; Rashidul Haque; William A Petri
Journal:  Clin Infect Dis       Date:  2012-12-12       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.